Health Ministry halts use of Similac batch following complaint

The Health Ministry has ordered a halt to the use of a batch of Similac infant formula, intended exclusively for hospitals, following a specific complaint received. No medical harm has been reported at this stage, and the directive applies only to the specific batch.

The Health Ministry has ordered a halt to the use of one batch of Similac infant formula, intended exclusively for hospitals. The decision was made following a specific complaint received yesterday (Saturday) evening. No medical harm or additional complaints have been reported at this stage. The batch in question bears the number 89203N201, imprinted on the bottom of the bottle. The directive applies only to this batch, and there are no restrictions on other batches of the product. Abbott, the manufacturer of Similac, is working to supply an alternative batch to hospitals. The product is not sold retail in marketing chains.